Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents

Shrouq I. Farah, Abd Almonem Abdelrahman, E. Jeffrey North, Harsh Chauhan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Current tuberculosis (TB) treatment suffers from complexity of the dosage regimens, length of treatment, and toxicity risks. Many natural products have shown activity against drug-susceptible, drug-resistant, and latent/dormant Mycobacterium tuberculosis, the pathogen responsible for TB infections. Natural sources, including plants, fungi, and bacteria, provide a rich source of chemically diverse compounds equipped with unique pharmacological, pharmacokinetic, and pharmacodynamic properties. This review focuses on natural products as starting points for the discovery and development of novel anti-TB chemotherapy and classifies them based on their chemical nature. The classes discussed are divided into alkaloids, chalcones, flavonoids, peptides, polyketides, steroids, and terpenes. This review also highlights the importance of collaboration between phytochemistry, medicinal chemistry, and physical chemistry, which is very important for the development of these natural compounds.

Original languageEnglish (US)
Pages (from-to)29-38
Number of pages10
JournalAssay and Drug Development Technologies
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Biological Products
Tuberculosis
Physical Chemistry
Chalcones
Polyketides
Pharmaceutical Chemistry
Terpenes
Mycobacterium tuberculosis
Alkaloids
Flavonoids
Pharmaceutical Preparations
Fungi
Pharmacokinetics
Steroids
Pharmacology
Bacteria
Drug Therapy
Peptides
Therapeutics
Infection

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this

Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents. / Farah, Shrouq I.; Abdelrahman, Abd Almonem; North, E. Jeffrey; Chauhan, Harsh.

In: Assay and Drug Development Technologies, Vol. 14, No. 1, 01.01.2016, p. 29-38.

Research output: Contribution to journalArticle

@article{5806087ffef24c749837d3d005beafe8,
title = "Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents",
abstract = "Current tuberculosis (TB) treatment suffers from complexity of the dosage regimens, length of treatment, and toxicity risks. Many natural products have shown activity against drug-susceptible, drug-resistant, and latent/dormant Mycobacterium tuberculosis, the pathogen responsible for TB infections. Natural sources, including plants, fungi, and bacteria, provide a rich source of chemically diverse compounds equipped with unique pharmacological, pharmacokinetic, and pharmacodynamic properties. This review focuses on natural products as starting points for the discovery and development of novel anti-TB chemotherapy and classifies them based on their chemical nature. The classes discussed are divided into alkaloids, chalcones, flavonoids, peptides, polyketides, steroids, and terpenes. This review also highlights the importance of collaboration between phytochemistry, medicinal chemistry, and physical chemistry, which is very important for the development of these natural compounds.",
author = "Farah, {Shrouq I.} and Abdelrahman, {Abd Almonem} and North, {E. Jeffrey} and Harsh Chauhan",
year = "2016",
month = "1",
day = "1",
doi = "10.1089/adt.2015.673",
language = "English (US)",
volume = "14",
pages = "29--38",
journal = "Assay and Drug Development Technologies",
issn = "1540-658X",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents

AU - Farah, Shrouq I.

AU - Abdelrahman, Abd Almonem

AU - North, E. Jeffrey

AU - Chauhan, Harsh

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Current tuberculosis (TB) treatment suffers from complexity of the dosage regimens, length of treatment, and toxicity risks. Many natural products have shown activity against drug-susceptible, drug-resistant, and latent/dormant Mycobacterium tuberculosis, the pathogen responsible for TB infections. Natural sources, including plants, fungi, and bacteria, provide a rich source of chemically diverse compounds equipped with unique pharmacological, pharmacokinetic, and pharmacodynamic properties. This review focuses on natural products as starting points for the discovery and development of novel anti-TB chemotherapy and classifies them based on their chemical nature. The classes discussed are divided into alkaloids, chalcones, flavonoids, peptides, polyketides, steroids, and terpenes. This review also highlights the importance of collaboration between phytochemistry, medicinal chemistry, and physical chemistry, which is very important for the development of these natural compounds.

AB - Current tuberculosis (TB) treatment suffers from complexity of the dosage regimens, length of treatment, and toxicity risks. Many natural products have shown activity against drug-susceptible, drug-resistant, and latent/dormant Mycobacterium tuberculosis, the pathogen responsible for TB infections. Natural sources, including plants, fungi, and bacteria, provide a rich source of chemically diverse compounds equipped with unique pharmacological, pharmacokinetic, and pharmacodynamic properties. This review focuses on natural products as starting points for the discovery and development of novel anti-TB chemotherapy and classifies them based on their chemical nature. The classes discussed are divided into alkaloids, chalcones, flavonoids, peptides, polyketides, steroids, and terpenes. This review also highlights the importance of collaboration between phytochemistry, medicinal chemistry, and physical chemistry, which is very important for the development of these natural compounds.

UR - http://www.scopus.com/inward/record.url?scp=84979734812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979734812&partnerID=8YFLogxK

U2 - 10.1089/adt.2015.673

DO - 10.1089/adt.2015.673

M3 - Article

VL - 14

SP - 29

EP - 38

JO - Assay and Drug Development Technologies

JF - Assay and Drug Development Technologies

SN - 1540-658X

IS - 1

ER -